Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Search Result Details

This page shows the details of why an item matched the keywords from your search.
One or more keywords matched the following items that are connected to Reardon, David
Item TypeName
Academic Article Tandem-cycle high-dose melphalan and cisplatin with peripheral blood progenitor cell support in patients with breast cancer and other malignancies.
Academic Article Tamoxifen and carboplatin for children with low-grade gliomas: a pilot study at St. Jude Children's Research Hospital.
Academic Article MOPP or radiation in addition to ABVD in the treatment of pathologically staged advanced Hodgkin's disease in children: results of the Children's Cancer Group Phase III Trial.
Academic Article Quantitative assessment of cardiorespiratory fitness, skeletal muscle function, and body composition in adults with primary malignant glioma.
Academic Article High-dose paclitaxel in combination with doxorubicin, cyclophosphamide and peripheral blood progenitor cell rescue in patients with high-risk primary and responding metastatic breast carcinoma: toxicity profile, relationship to paclitaxel pharmacokinetics and short-term outcome.
Academic Article Phase II trial of murine (131)I-labeled antitenascin monoclonal antibody 81C6 administered into surgically created resection cavities of patients with newly diagnosed malignant gliomas.
Academic Article Exercise interest and preferences among patients diagnosed with primary brain cancer.
Academic Article Clinical utility of a patient-specific algorithm for simulating intracerebral drug infusions.
Academic Article Bithalamic involvement predicts poor outcome among children with thalamic glial tumors.
Academic Article It is time to include patients with brain tumors in phase I trials in oncology.
Academic Article Phase II study of carboplatin, irinotecan, and bevacizumab for bevacizumab naïve, recurrent glioblastoma.
Academic Article Temozolomide in children with progressive low-grade glioma.
Academic Article Progress report of a Phase I study of the intracerebral microinfusion of a recombinant chimeric protein composed of transforming growth factor (TGF)-alpha and a mutated form of the Pseudomonas exotoxin termed PE-38 (TP-38) for the treatment of malignant brain tumors.
Academic Article Glioblastoma multiforme: an emerging paradigm of anti-VEGF therapy.
Academic Article Immunotherapy against angiogenesis-associated targets: evidence and implications for the treatment of malignant glioma.
Academic Article Overall survival of newly diagnosed glioblastoma patients receiving carmustine wafers followed by radiation and concurrent temozolomide plus rotational multiagent chemotherapy.
Academic Article A phase II study evaluating the efficacy and safety of AMG 102 (rilotumumab) in patients with recurrent glioblastoma.
Academic Article Phase I trial of temozolomide plus O6-benzylguanine for patients with recurrent or progressive malignant glioma.
Academic Article Phase II study of imatinib mesylate plus hydroxyurea in adults with recurrent glioblastoma multiforme.
Academic Article Using the theory of planned behavior to understand the determinants of exercise intention in patients diagnosed with primary brain cancer.
Academic Article Efficacy of high-dose chemotherapy or standard salvage therapy in patients with recurrent medulloblastoma.
Academic Article Cilengitide: an integrin-targeting arginine-glycine-aspartic acid peptide with promising activity for glioblastoma multiforme.
Academic Article Phase 1 trial of temozolomide plus irinotecan plus O6-benzylguanine in adults with recurrent malignant glioma.
Academic Article Effect of CYP3A-inducing anti-epileptics on sorafenib exposure: results of a phase II study of sorafenib plus daily temozolomide in adults with recurrent glioblastoma.
Academic Article Current and future directions for Phase II trials in high-grade glioma.
Academic Article Response assessment in neuro-oncology (a report of the RANO group): assessment of outcome in trials of diffuse low-grade gliomas.
Academic Article Multifocal anaplastic astrocytoma in a patient with hereditary colorectal cancer, transcobalamin II deficiency, agenesis of the corpus callosum, mental retardation, and inherited PMS2 mutation.
Academic Article Tinzaparin prophylaxis against venous thromboembolic complications in brain tumor patients.
Academic Article Vascular endothelial growth factor targeted therapy in the perioperative setting: implications for patient care.
Academic Article ZD6474, a novel tyrosine kinase inhibitor of vascular endothelial growth factor receptor and epidermal growth factor receptor, inhibits tumor growth of multiple nervous system tumors.
Academic Article Novel human IgG2b/murine chimeric antitenascin monoclonal antibody construct radiolabeled with 131I and administered into the surgically created resection cavity of patients with malignant glioma: phase I trial results.
Academic Article Diagnosis and treatment of high-grade astrocytoma.
Academic Article An epidermal growth factor receptor variant III-targeted vaccine is safe and immunogenic in patients with glioblastoma multiforme.
Academic Article Phase I study of AEE788, a novel multitarget inhibitor of ErbB- and VEGF-receptor-family tyrosine kinases, in recurrent glioblastoma patients.
Academic Article Phase 2 study of carboplatin, irinotecan, and bevacizumab for recurrent glioblastoma after progression on bevacizumab therapy.
Academic Article A review of VEGF/VEGFR-targeted therapeutics for recurrent glioblastoma.
Academic Article Salvage radioimmunotherapy with murine iodine-131-labeled antitenascin monoclonal antibody 81C6 for patients with recurrent primary and metastatic malignant brain tumors: phase II study results.
Academic Article Phase II study of carboplatin in children with progressive low-grade gliomas.
Academic Article Kluver-Bucy syndrome related to glioma.
Academic Article Phase II study of metronomic chemotherapy with bevacizumab for recurrent glioblastoma after progression on bevacizumab therapy.
Academic Article Mibefradil, a novel therapy for glioblastoma multiforme: cell cycle synchronization and interlaced therapy in a murine model.
Academic Article Survival and neurodevelopmental outcome of young children with medulloblastoma at St Jude Children's Research Hospital.
Academic Article The relative role of ErbB1-4 receptor tyrosine kinases in radiation signal transduction responses of human carcinoma cells.
Academic Article High-dose chemotherapy with autologous stem-cell rescue in children and adults with newly diagnosed pineoblastomas.
Academic Article Patterns of exercise across the cancer trajectory in brain tumor patients.
Academic Article Phase II trial of bevacizumab and irinotecan in recurrent malignant glioma.
Academic Article Sustained radiographic and clinical response in patient with bifrontal recurrent glioblastoma multiforme with intracerebral infusion of the recombinant targeted toxin TP-38: case study.
Academic Article Dosimetry and radiographic analysis of 131I-labeled anti-tenascin 81C6 murine monoclonal antibody in newly diagnosed patients with malignant gliomas: a phase II study.
Academic Article Glioblastoma--more questions than answers?
Academic Article Glycoprotein nonmetastatic melanoma protein B, a potential molecular therapeutic target in patients with glioblastoma multiforme.
Academic Article Induction of hyperintense signal on T2-weighted MR images correlates with infusion distribution from intracerebral convection-enhanced delivery of a tumor-targeted cytotoxin.
Academic Article Clinical experience with alpha-particle emitting 211At: treatment of recurrent brain tumor patients with 211At-labeled chimeric antitenascin monoclonal antibody 81C6.
Academic Article Intracerebral infusion of an EGFR-targeted toxin in recurrent malignant brain tumors.
Academic Article Experience with irinotecan for the treatment of malignant glioma.
Academic Article Poor drug distribution as a possible explanation for the results of the PRECISE trial.
Academic Article Dose-dense temozolomide regimens: antitumor activity, toxicity, and immunomodulatory effects.
Academic Article Phase II trial of bevacizumab and erlotinib in patients with recurrent malignant glioma.
Academic Article Bevacizumab and daily temozolomide for recurrent glioblastoma.
Academic Article Ridaforolimus for patients with progressive or recurrent malignant glioma: a perisurgical, sequential, ascending-dose trial.
Academic Article Bevacizumab therapy for adults with recurrent/progressive meningioma: a retrospective series.
Academic Article Treatment of elderly patients with glioblastoma.
Academic Article A phase I/II trial of pazopanib in combination with lapatinib in adult patients with relapsed malignant glioma.
Academic Article Recent advances in the treatment of malignant astrocytoma.
Academic Article Phase II trial of carmustine plus O(6)-benzylguanine for patients with nitrosourea-resistant recurrent or progressive malignant glioma.
Academic Article Safety and efficacy of erlotinib in first-relapse glioblastoma: a phase II open-label study.
Academic Article Colocalization of gadolinium-diethylene triamine pentaacetic acid with high-molecular-weight molecules after intracerebral convection-enhanced delivery in humans.
Academic Article Incidence and patterns of neuraxis metastases in children with diffuse pontine glioma.
Academic Article Phase II study of imatinib mesylate and hydroxyurea for recurrent grade III malignant gliomas.
Academic Article A dose escalation trial for the combination of erlotinib and sirolimus for recurrent malignant gliomas.
Academic Article Analysis of early hypertension and clinical outcome with bevacizumab: results from seven phase III studies.
Academic Article Tumor resection cavity administered iodine-131-labeled antitenascin 81C6 radioimmunotherapy in patients with malignant glioma: neuropathology aspects.
Academic Article Updated response assessment criteria for high-grade gliomas: response assessment in neuro-oncology working group.
Academic Article Immunologic escape after prolonged progression-free survival with epidermal growth factor receptor variant III peptide vaccination in patients with newly diagnosed glioblastoma.
Academic Article Phase I trial of temozolomide plus O6-benzylguanine 5-day regimen with recurrent malignant glioma.
Academic Article Incorporation of biomarker assessment in novel clinical trial designs: personalizing brain tumor treatments.
Academic Article Cilengitide: a prototypic integrin inhibitor for the treatment of glioblastoma and other malignancies.
Academic Article IDH1 and IDH2 mutations in gliomas.
Academic Article Targeting integrins in malignant glioma.
Academic Article The addition of bevacizumab to standard radiation therapy and temozolomide followed by bevacizumab, temozolomide, and irinotecan for newly diagnosed glioblastoma.
Academic Article Bevacizumab continuation beyond initial bevacizumab progression among recurrent glioblastoma patients.
Academic Article A pilot study: 131I-antitenascin monoclonal antibody 81c6 to deliver a 44-Gy resection cavity boost.
Academic Article Assessment of physical functioning in recurrent glioma: preliminary comparison of performance status to functional capacity testing.
Academic Article Changes in functional performance measures in adults undergoing chemoradiation for primary malignant glioma: a feasibility study.
Academic Article Pharmacokinetic drug interaction between AEE788 and RAD001 causing thrombocytopenia in patients with glioblastoma.
Academic Article Multicenter phase II study of rituximab and temozolomide in recurrent primary central nervous system lymphoma.
Academic Article Phase I study of temozolomide and escalating doses of oral etoposide for adults with recurrent malignant glioma.
Academic Article A pilot study of IL-2Ra blockade during lymphopenia depletes regulatory T-cells and correlates with enhanced immunity in patients with glioblastoma.
Academic Article Identification of PATCHED mutations in medulloblastomas by direct sequencing.
Academic Article Monoclonal antibodies for brain tumour treatment.
Academic Article Irinotecan: promising activity in the treatment of malignant glioma.
Academic Article Computerized assessment of vessel morphological changes during treatment of glioblastoma multiforme: report of a case imaged serially by MRA over four years.
Academic Article Phase 2 trial of erlotinib plus sirolimus in adults with recurrent glioblastoma.
Academic Article Prognostic significance of parameters derived from co-registered 18F-fluorodeoxyglucose PET and contrast-enhanced MRI in patients with high-grade glioma.
Academic Article Addition of bevacizumab to standard radiation therapy and daily temozolomide is associated with minimal toxicity in newly diagnosed glioblastoma multiforme.
Academic Article A novel method for volumetric MRI response assessment of enhancing brain tumors.
Academic Article Phase II trial of irinotecan plus celecoxib in adults with recurrent malignant glioma.
Academic Article Is there really a yin and yang to VEGF-targeted therapies?
Academic Article Greater chemotherapy-induced lymphopenia enhances tumor-specific immune responses that eliminate EGFRvIII-expressing tumor cells in patients with glioblastoma.
Academic Article Clinical trial end points for high-grade glioma: the evolving landscape.
Academic Article Safety and efficacy of stereotactic radiosurgery and adjuvant bevacizumab in patients with recurrent malignant gliomas.
Academic Article Therapeutic advances in the treatment of glioblastoma: rationale and potential role of targeted agents.
Academic Article 3'-Deoxy-3'-[F-18]fluorothymidine positron emission tomography in patients with recurrent glioblastoma multiforme: comparison with Gd-DTPA enhanced magnetic resonance imaging.
Academic Article Phase II trial of Gliadel plus O6-benzylguanine in adults with recurrent glioblastoma multiforme.
Academic Article Phase II trial of temozolomide plus o6-benzylguanine in adults with recurrent, temozolomide-resistant malignant glioma.
Academic Article Multicentre phase II studies evaluating imatinib plus hydroxyurea in patients with progressive glioblastoma.
Academic Article Monoclonal antibody blockade of IL-2 receptor a during lymphopenia selectively depletes regulatory T cells in mice and humans.
Academic Article Everolimus tablets for patients with subependymal giant cell astrocytoma.
Academic Article Current clinical development of PI3K pathway inhibitors in glioblastoma.
Academic Article Comparison of lumbar and shunt cerebrospinal fluid specimens for cytologic detection of leptomeningeal disease in pediatric patients with brain tumors.
Academic Article Ulceration of Striae distensae in high-grade glioma patients on concurrent systemic corticosteroid and bevacizumab therapy.
Academic Article Phase I study of sunitinib and irinotecan for patients with recurrent malignant glioma.
Academic Article Phase II study of Gleevec® plus hydroxyurea (HU) in adults with progressive or recurrent meningioma.
Academic Article Phase 1 trial of gefitinib plus sirolimus in adults with recurrent malignant glioma.
Academic Article Phase II trial of temozolomide (TMZ) plus irinotecan (CPT-11) in adults with newly diagnosed glioblastoma multiforme before radiotherapy.
Academic Article Exercise behavior, functional capacity, and survival in adults with malignant recurrent glioma.
Academic Article Bevacizumab-induced reversible posterior leukoencephalopathy syndrome and successful retreatment in a patient with glioblastoma.
Academic Article Molecularly targeted therapy for malignant glioma.
Academic Article Phase II study of Cloretazine for the treatment of adults with recurrent glioblastoma multiforme.
Academic Article The emerging role of anti-angiogenic therapy for malignant glioma.
Academic Article Metronomic chemotherapy with daily, oral etoposide plus bevacizumab for recurrent malignant glioma: a phase II study.
Academic Article Differential sensitivity of glioma- versus lung cancer-specific EGFR mutations to EGFR kinase inhibitors.
Academic Article Phase II trial of gefitinib in recurrent glioblastoma.
Academic Article Chemotherapy and novel therapeutic approaches in malignant glioma.
Academic Article Antitenascin-C monoclonal antibody radioimmunotherapy for malignant glioma patients.
Academic Article Safety and pharmacokinetics of dose-intensive imatinib mesylate plus temozolomide: phase 1 trial in adults with malignant glioma.
Academic Article Cancer: The nuances of therapy.
Academic Article A phase I trial of the farnesyl transferase inhibitor, SCH 66336, with temozolomide for patients with malignant glioma.
Academic Article Phase II study of Gleevec plus hydroxyurea in adults with progressive or recurrent low-grade glioma.
Academic Article Phase 2 trial design in neuro-oncology revisited: a report from the RANO group.
Academic Article Phase I trial of irinotecan plus temozolomide in adults with recurrent malignant glioma.
Academic Article Survival analysis of presumptive prognostic markers among oligodendrogliomas.
Academic Article Bevacizumab plus irinotecan in recurrent WHO grade 3 malignant gliomas.
Academic Article Phase I pharmacokinetic study of the vascular endothelial growth factor receptor tyrosine kinase inhibitor vatalanib (PTK787) plus imatinib and hydroxyurea for malignant glioma.
Academic Article Treatment recommendations for primary extradural meningiomas.
Academic Article Outcome after bevacizumab clinical trial therapy among recurrent grade III malignant glioma patients.
Academic Article Phase 1 trial of dasatinib plus erlotinib in adults with recurrent malignant glioma.
Academic Article A novel treatment for glioblastoma: integrin inhibition.
Concept Infratentorial Neoplasms
Concept Breast Neoplasms
Concept Bone Neoplasms
Concept Abdominal Neoplasms
Concept Head and Neck Neoplasms
Concept Immunotherapy, Adoptive
Concept Meningeal Neoplasms
Concept Colorectal Neoplasms
Concept Cancer Vaccines
Concept Pancreatic Neoplasms
Concept Optic Nerve Neoplasms
Concept Pituitary Neoplasms
Concept Kidney Neoplasms
Concept Immunotherapy
Concept Brain Neoplasms
Concept Lung Neoplasms
Concept Skin Neoplasms
Concept Brain Stem Neoplasms
Concept Neoplasms
Concept Colorectal Neoplasms, Hereditary Nonpolyposis
Concept Choroid Plexus Neoplasms
Concept Early Detection of Cancer
Concept Central Nervous System Neoplasms
Concept Nervous System Neoplasms
Concept Uterine Cervical Neoplasms
Concept Hematologic Neoplasms
Concept Spinal Cord Neoplasms
Concept Cerebellar Neoplasms
Academic Article Recurrent glioblastoma: volumetric assessment and stratification of patient survival with early posttreatment magnetic resonance imaging in patients treated with bevacizumab.
Academic Article Extensive genomic abnormalities in childhood medulloblastoma by comparative genomic hybridization.
Academic Article Multiple genomic alterations including N-myc amplification in a primary large cell medulloblastoma.
Academic Article Biomarker-based adaptive trials for patients with glioblastoma--lessons from I-SPY 2.
Academic Article Chromosome arm 6q loss is the most common recurrent autosomal alteration detected in primary pediatric ependymoma.
Academic Article An update on vaccine therapy and other immunotherapeutic approaches for glioblastoma.
Academic Article Phase II trial of upfront bevacizumab and temozolomide for unresectable or multifocal glioblastoma.
Academic Article Lineage switch in Philadelphia chromosome-positive acute lymphoblastic leukemia.
Academic Article Targeted alpha-particle radiotherapy with 211At-labeled monoclonal antibodies.
Academic Article A review of micro- and macrovascular analyses in the assessment of tumor-associated vasculature as visualized by MR.
Academic Article PCV for anaplastic oligodendrogliomas: back to the future or a step backwards? A point/counterpoint discussion.
Academic Article Antiangiogenic therapy for glioblastoma: the challenge of translating response rate into efficacy.
Academic Article Knee deep in the nerve.
Academic Article Update on bevacizumab and other angiogenesis inhibitors for brain cancer.
Academic Article O6-methylguanine-DNA methyltransferase (MGMT) immunohistochemistry as a predictor of resistance to temozolomide in primary CNS lymphoma.
Academic Article Pediatric choroid plexus neoplasms.
Academic Article Current status of antiangiogenic therapies for glioblastomas.
Academic Article Treatment options and outcomes for glioblastoma in the elderly patient.
Academic Article Histogram analysis of apparent diffusion coefficient within enhancing and nonenhancing tumor volumes in recurrent glioblastoma patients treated with bevacizumab.
Academic Article Targeted therapies: Further delineating bevacizumab's response spectrum.
Academic Article Retrospective study of carmustine or lomustine with bevacizumab in recurrent glioblastoma patients who have failed prior bevacizumab.
Academic Article Adjuvant radiation therapy, local recurrence, and the need for salvage therapy in atypical meningioma.
Academic Article Update on the use of angiogenesis inhibitors in adult patients with brain tumors.
Academic Article A novel, reproducible, and objective method for volumetric magnetic resonance imaging assessment of enhancing glioblastoma.
Academic Article Cilengitide combined with standard treatment for patients with newly diagnosed glioblastoma with methylated MGMT promoter (CENTRIC EORTC 26071-22072 study): a multicentre, randomised, open-label, phase 3 trial.
Academic Article Clinical multiplexed exome sequencing distinguishes adult oligodendroglial neoplasms from astrocytic and mixed lineage gliomas.
Academic Article The future of antiangiogenic treatment in glioblastoma.
Academic Article Antiangiogenic therapy for glioblastoma: current status and future prospects.
Academic Article Immunotherapy advances for glioblastoma.
Academic Article Impact of imaging measurements on response assessment in glioblastoma clinical trials.
Academic Article Report of the Jumpstarting Brain Tumor Drug Development Coalition and FDA clinical trials neuroimaging endpoint workshop (January 30, 2014, Bethesda MD).
Academic Article Targeted molecular therapies against epidermal growth factor receptor: past experiences and challenges.
Academic Article Increased expression of the immune modulatory molecule PD-L1 (CD274) in anaplastic meningioma.
Academic Article Clinical implementation of integrated whole-genome copy number and mutation profiling for glioblastoma.
Academic Article Hypofractionated versus standard radiation therapy with or without temozolomide for older glioblastoma patients.
Academic Article Phase II study of monthly pasireotide LAR (SOM230C) for recurrent or progressive meningioma.
Academic Article Phase 2 study of CT-322, a targeted biologic inhibitor of VEGFR-2 based on a domain of human fibronectin, in recurrent glioblastoma.
Academic Article Bevacizumab and glioblastoma: scientific review, newly reported updates, and ongoing controversies.
Academic Article Medical management of brain tumors and the sequelae of treatment.
Academic Article Two cilengitide regimens in combination with standard treatment for patients with newly diagnosed glioblastoma and unmethylated MGMT gene promoter: results of the open-label, controlled, randomized phase II CORE study.
Academic Article A phase II, multicenter trial of rindopepimut (CDX-110) in newly diagnosed glioblastoma: the ACT III study.
Academic Article Phase II study of panobinostat in combination with bevacizumab for recurrent glioblastoma and anaplastic glioma.
Academic Article A phase 1 study of ABT-806 in subjects with advanced solid tumors.
Academic Article Tetanus toxoid and CCL3 improve dendritic cell vaccines in mice and glioblastoma patients.
Academic Article Phase II Trial of Upfront Bevacizumab, Irinotecan, and Temozolomide for Unresectable Glioblastoma.
Academic Article Phase I/randomized phase II study of afatinib, an irreversible ErbB family blocker, with or without protracted temozolomide in adults with recurrent glioblastoma.
Academic Article Incidence, risk factors, and reasons for hospitalization among glioblastoma patients receiving chemoradiation.
Academic Article Re-defining response and treatment effects for neuro-oncology immunotherapy clinical trials.
Academic Article Programmed death ligand 1 (PD-L1) as an immunotherapy target in patients with glioblastoma.
Academic Article One size should not fit all: advancing toward personalized glioblastoma therapy.
Academic Article Rindopepimut vaccine and bevacizumab combination therapy: improving survival rates in relapsed glioblastoma patients?
Academic Article Brachytherapy in the treatment of recurrent aggressive falcine meningiomas.
Academic Article Rapid Intraoperative Molecular Characterization of Glioma.
Academic Article A prognostic cytogenetic scoring system to guide the adjuvant management of patients with atypical meningioma.
Academic Article Prospects of immune checkpoint modulators in the treatment of glioblastoma.
Academic Article Multicentric Low-Grade Gliomas.
Academic Article An Update on the Role of Immunotherapy and Vaccine Strategies for Primary Brain Tumors.
Academic Article The Impact of T2/FLAIR Evaluation per RANO Criteria on Response Assessment of Recurrent Glioblastoma Patients Treated with Bevacizumab.
Academic Article Immunotherapy response assessment in neuro-oncology: a report of the RANO working group.
Academic Article Afatinib, an irreversible ErbB family blocker, with protracted temozolomide in recurrent glioblastoma: a case report.
Academic Article Introduction.
Academic Article Immunotherapy for neuro-oncology: the critical rationale for combinatorial therapy.
Academic Article Extent of resection and overall survival for patients with atypical and malignant meningioma.
Academic Article Oncogenic PI3K mutations are as common as AKT1 and SMO mutations in meningioma.
Academic Article Adult Atypical Teratoid/Rhabdoid Tumors.
Academic Article Phase 1 dose escalation trial of the safety and pharmacokinetics of cabozantinib concurrent with temozolomide and radiotherapy or temozolomide after radiotherapy in newly diagnosed patients with high-grade gliomas.
Academic Article Glioblastoma Eradication Following Immune Checkpoint Blockade in an Orthotopic, Immunocompetent Model.
Academic Article Does Valproic Acid or Levetiracetam Improve Survival in Glioblastoma? A Pooled Analysis of Prospective Clinical Trials in Newly Diagnosed Glioblastoma.
Academic Article Rare glial tumors.
Academic Article Neuro-oncology in 2015: Progress in glioma diagnosis, classification and treatment.
Academic Article MAPK activation and HRAS mutation identified in pituitary spindle cell oncocytoma.
Academic Article Checkpoint inhibition in meningiomas.
Academic Article Multimodal imaging patterns predict survival in recurrent glioblastoma patients treated with bevacizumab.
Academic Article Multimodal MRI features predict isocitrate dehydrogenase genotype in high-grade gliomas.
Academic Article Radiation therapy for glioblastoma: Executive summary of an American Society for Radiation Oncology Evidence-Based Clinical Practice Guideline.
Grant SPORE in Brain Cancer
Grant SPORE in Brain Cancer
Academic Article Adult brainstem gliomas.
Academic Article The Clinical Implications of Inconsistently Methylated Results from Glioblastoma MGMT Testing by Replicate Methylation-Specific PCR.
Academic Article Increased expression of programmed death ligand 1 (PD-L1) in human pituitary tumors.
Academic Article A methods study to define the performance specifications of MHC tetramer assays for immune monitoring of tumor immunotherapy.
Academic Article Efficacy and safety results of ABT-414 in combination with radiation and temozolomide in newly diagnosed glioblastoma.
Academic Article Advanced MRI assessment to predict benefit of anti-programmed cell death 1 protein immunotherapy response in patients with recurrent glioblastoma.
Academic Article The development of dendritic cell vaccine-based immunotherapies for glioblastoma.
Academic Article Germline and somatic BAP1 mutations in high-grade rhabdoid meningiomas.
Academic Article Critical review of the addition of tumor treating fields (TTFields) to the existing standard of care for newly diagnosed glioblastoma patients.
Academic Article Immunomodulation for glioblastoma.
Academic Article Is more better? The impact of extended adjuvant temozolomide in newly diagnosed glioblastoma: a secondary analysis of EORTC and NRG Oncology/RTOG.
Academic Article Angiogenesis inhibitors in tackling recurrent glioblastoma.
Academic Article Quantitative imaging biomarkers for risk stratification of patients with recurrent glioblastoma treated with bevacizumab.
Academic Article Vaccine-based immunotherapeutic approaches to gliomas and beyond.
Academic Article The Neurologic Assessment in Neuro-Oncology (NANO) scale: a tool to assess neurologic function for integration into the Response Assessment in Neuro-Oncology (RANO) criteria.
Academic Article Antibody-drug conjugates in glioblastoma therapy: the right drugs to the right cells.
Academic Article Salvage re-irradiation for recurrent high-grade glioma and comparison to bevacizumab alone.
Academic Article Preclinical investigation of combined gene-mediated cytotoxic immunotherapy and immune checkpoint blockade in glioblastoma.
Academic Article Safety, pharmacokinetics, and antitumor response of depatuxizumab mafodotin as monotherapy or in combination with temozolomide in patients with glioblastoma.
Academic Article Efficacy of depatuxizumab mafodotin (ABT-414) monotherapy in patients with EGFR-amplified, recurrent glioblastoma: results from a multi-center, international study.
Academic Article Nivolumab with or without ipilimumab in patients with recurrent glioblastoma: results from exploratory phase I cohorts of CheckMate 143.
Academic Article Phase II Study of Bevacizumab and Vorinostat for Patients with Recurrent World Health Organization Grade 4 Malignant Glioma.
Academic Article Phase 2 and biomarker study of trebananib, an angiopoietin-blocking peptibody, with and without bevacizumab for patients with recurrent glioblastoma.
Academic Article Phase I/II trial of vorinostat, bevacizumab, and daily temozolomide for recurrent malignant gliomas.
Academic Article Immunotherapy for glioblastoma: on the sidelines or in the game?
Academic Article Modeling tumor immunity of mouse glioblastoma by exhausted CD8+ T cells.
Academic Article Diagnostic accuracy of 2-hydroxyglutarate magnetic resonance spectroscopy in newly diagnosed brain mass and suspected recurrent gliomas.
Academic Article Do statins, ACE inhibitors or sartans improve outcome in primary glioblastoma?
Academic Article Multiplexed immunofluorescence reveals potential PD-1/PD-L1 pathway vulnerabilities in craniopharyngioma.
Academic Article Concepts for Immunotherapies in Gliomas.
Academic Article Toxicity and Efficacy of a Novel GADD34-expressing Oncolytic HSV-1 for the Treatment of Experimental Glioblastoma.
Academic Article Volumetric response quantified using T1 subtraction predicts long-term survival benefit from cabozantinib monotherapy in recurrent glioblastoma.
Academic Article Bevacizumab biosimilars: scientific justification for extrapolation of indications.
Academic Article Corticosteroid use endpoints in neuro-oncology: Response Assessment in Neuro-Oncology Working Group.
Academic Article Phase I and Biomarker Study of Plerixafor and Bevacizumab in Recurrent High-Grade Glioma.
Academic Article Safety and efficacy of depatuxizumab mafodotin + temozolomide in patients with EGFR-amplified, recurrent glioblastoma: results from an international phase I multicenter trial.
Academic Article Improved Risk-Adjusted Survival for Melanoma Brain Metastases in the Era of Checkpoint Blockade Immunotherapies: Results from a National Cohort.
Academic Article Epidermal Growth Factor Receptor Extracellular Domain Mutations in Glioblastoma Present Opportunities for Clinical Imaging and Therapeutic Development.
Academic Article Associations of anticoagulant use with outcome in newly diagnosed glioblastoma.
Academic Article Immunotherapy for glioblastoma: going viral.
Academic Article Proposed response assessment and endpoints for meningioma clinical trials: report from the Response Assessment in Neuro-Oncology Working Group.
Academic Article Combined Nivolumab and Ipilimumab in Melanoma Metastatic to the Brain.
Academic Article PD-1 inhibition has only limited clinical benefit in patients with recurrent high-grade glioma.
Academic Article Arming an Oncolytic Herpes Simplex Virus Type 1 with a Single-chain Fragment Variable Antibody against PD-1 for Experimental Glioblastoma Therapy.
Academic Article Voxel-Wise Analysis of Fluoroethyltyrosine PET and MRI in the Assessment of Recurrent Glioblastoma During Antiangiogenic Therapy.
Academic Article Pseudoprogression: fact or wishful thinking in neuro-oncology?
Academic Article Neoantigen vaccine generates intratumoral T cell responses in phase Ib glioblastoma trial.
Academic Article The Misclassification of Diffuse Gliomas: Rates and Outcomes.
Academic Article Buparlisib in Patients With Recurrent Glioblastoma Harboring Phosphatidylinositol 3-Kinase Pathway Activation: An Open-Label, Multicenter, Multi-Arm, Phase II Trial.
Academic Article Neoadjuvant anti-PD-1 immunotherapy promotes a survival benefit with intratumoral and systemic immune responses in recurrent glioblastoma.
Academic Article Efficacy and safety of immune checkpoint blockade for brain metastases.
Academic Article Survival and prognostic factors in surgically treated brain metastases.
Academic Article Control of tumor-associated macrophages and T cells in glioblastoma via AHR and CD39.
Academic Article Safety, tolerability, and pharmacokinetics of anti-EGFRvIII antibody-drug conjugate AMG 595 in patients with recurrent malignant glioma expressing EGFRvIII.
Academic Article Barriers to accrual and enrollment in brain tumor trials.
Academic Article A Randomized Double-Blind Placebo-Controlled Phase II Trial of Dendritic Cell Vaccine ICT-107 in Newly Diagnosed Patients with Glioblastoma.
Academic Article Phase II trial of ponatinib in patients with bevacizumab-refractory glioblastoma.
Academic Article Acoustic feedback enables safe and reliable carboplatin delivery across the blood-brain barrier with a clinical focused ultrasound system and improves survival in a rat glioma model.
Academic Article Molecular targeted therapy of glioblastoma.
Academic Article An Online Calculator for the Prediction of Survival in Glioblastoma Patients Using Classical Statistics and Machine Learning.
Academic Article Correction: Arming an Oncolytic Herpes Simplex Virus Type 1 with a Single-chain Fragment Variable Antibody against PD-1 for Experimental Glioblastoma Therapy.
Academic Article Rindopepimut with Bevacizumab for Patients with Relapsed EGFRvIII-Expressing Glioblastoma (ReACT): Results of a Double-Blind Randomized Phase II Trial.
Academic Article Deep-Learning Detection of Cancer Metastases to the Brain on MRI.
Academic Article NRG/RTOG 1122: A phase 2, double-blinded, placebo-controlled study of bevacizumab with and without trebananib in patients with recurrent glioblastoma or gliosarcoma.
Academic Article Mechanisms and therapeutic implications of hypermutation in gliomas.
Academic Article Tumor Interferon Signaling Is Regulated by a lncRNA INCR1 Transcribed from the PD-L1 Locus.
Academic Article PD-1 Inhibitors: Do they have a Future in the Treatment of Glioblastoma?
Academic Article Emerging immunotherapies for malignant glioma: from immunogenomics to cell therapy.
Academic Article Appropriate Analysis of Duration of Response Data in Cancer Trials-Reply.
Search Criteria
  • Cancer
  • immunotherapy
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.